Clinical, Imaging, and Serum Biomarker Predictors of Malignant Cerebral Infarction
Journal of Cardiovascular Development and Disease · 04.10.2025 · 12 (10) · 392
DOI: 10.3390/jcdd12100392 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Development and Disease, online erschienen am 04.10.2025. Verfasst von Alejandro Rodríguez-Vázquez und 16 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Universitat de Barcelona, 170 Villarroel, 08036 Barcelona, Spain. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Social Fund, Spanish Ministry of Health.
Abstract (Originalsprache)
Malignant cerebral infarction (MCI) is rare but often fatal. Early identification helps guide monitoring and decompressive surgery. This study evaluated whether serum biomarkers add predictive value beyond clinical and imaging data in severe stroke patients with anterior circulation large vessel occlusion (LVO). In this prospective study, 73 acute severe LVO stroke patients underwent whole-brain CT perfusion (CTP) with rCBV-based core measurement at admission and follow-up MRI at 24 ± 12 h for infarct and edema volume assessment. Serum biomarkers (s100b, NSE, VEGF, ICAM1) were sampled a median of 20.5 h after baseline imaging. Logistic regression models predicted MCI using baseline variables (NIHSS, ASPECTS, rCBV < 30%), adding treatment data (rtPA, mTICI, NIHSS posttreatment), and adding serum biomarkers. Performance was assessed by AUC, accuracy, F1, and cross-validated R2. MCI occurred in 18/73 (24%) patients. Baseline models showed an AUC of 0.72; adding treatment improved the AUC to 0.88. Biomarkers slightly increased the AUC (0.90) but did not improve F1. Higher s100b was associated with more severe injury but did not enhance the prediction of MCI. Models with baseline imaging and treatment best explained infarct (R2 ≈ 0.27) and edema (R2 ≈ 0.58). In conclusion, admission severity, CTP, and early treatment response are the main predictors of MCI and aid early risk stratification of patients. Despite their pathophysiologic relevance, serum biomarkers do not add substantial predictive value.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Universitat de Barcelona, 170 Villarroel, 08036 Barcelona, Spain.
- Department of Neurology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
- Fundació de Recerca Clínic Barcelona-Institut d'Investigacions Biomèdiques August Pi i Sunyer (FRCB-IDIBAPS), 08036 Barcelona, Spain.
- Department of Radiology, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
- Department of Neurosurgery, Hospital Clínic de Barcelona, 08036 Barcelona, Spain.
ORCID-Profile: Alejandro Rodríguez-Vázquez, Salvatore Rudilosso, Andrea Cabero-Arnold, Carlos Laredo, Darío Ramis, Arturo Renú, Irene Rosa-Batlle, Guillem Dolz, Ramón Torné
Förderung
- Instituto de Salud Carlos III
- European Social Fund
- Spanish Ministry of Health
- European Social Fund «The ESF—Investing in your future»
- MINECO
Zitieren
APA
Rodríguez-Vázquez, A., Rudilosso, S., Doncel-Moriano, A., Cabero-Arnold, A., Laredo, C., Ramis, D., Moraleja, D., Serrano, M., González-Romero, Y., Renú, A., Bartolomé-Arenas, I., Rosa-Batlle, I., Dolz, G., Torné, R., Vargas, M., Urra, X., & Chamorro, Á. (2025). Clinical, Imaging, and Serum Biomarker Predictors of Malignant Cerebral Infarction. Journal of Cardiovascular Development and Disease, 12(10), 392. https://doi.org/10.3390/jcdd12100392
Vancouver
Rodríguez-Vázquez A, Rudilosso S, Doncel-Moriano A, Cabero-Arnold A, Laredo C, Ramis D, et al. Clinical, Imaging, and Serum Biomarker Predictors of Malignant Cerebral Infarction. Journal of Cardiovascular Development and Disease. 2025;12(10):392. doi:10.3390/jcdd12100392
BibTeX
@article{RodrguezVzquez2025,
author = {Rodríguez-Vázquez, Alejandro and Rudilosso, Salvatore and Doncel-Moriano, Antonio and Cabero-Arnold, Andrea and Laredo, Carlos and Ramis, Darío and Moraleja, David and Serrano, Mònica and González-Romero, Yolanda and Renú, Arturo and Bartolomé-Arenas, Inés and Rosa-Batlle, Irene and Dolz, Guillem and Torné, Ramón and Vargas, Martha and Urra, Xabier and Chamorro, Ángel},
title = {Clinical, Imaging, and Serum Biomarker Predictors of Malignant Cerebral Infarction},
journal = {Journal of Cardiovascular Development and Disease},
year = {2025},
volume = {12},
number = {10},
pages = {392},
doi = {10.3390/jcdd12100392}
}
EUVIMED